Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Jeffrey Kindler, former chairman and CEO of Pfizer, has joined Blackstone as a senior adviser. EQT Partners named Olof Svensson as its new head of shareholder relations....
...(FT) Japan Inc goes global for M&A advice Only three domestic brokerages rank among the top-ten deal advisers in Japan during the third quarter. Why is Japan Inc looking for foreign advice?...
...Warren East is trying to prevent Rolls-Royce going west with his restructuring plan, Pfizer is under fire for its tax inversion deal with Allergan....
...The Dowling Review found that Pfizer had the third most collaborations overall behind GlaxoSmithKline and Rolls-Royce of the UK....
...Pfizer (Biotech & Pharma) 36. JPMorgan Chase (Finance) 37. Diageo (Consumer Goods) 38. General Electric (Industrial conglomerate) 39. Chevron (Oil & Gas) 40. Deutsche Bank (Finance) 41....
...However, a takeover of Shire, whose market capitalisation exceeds that of household names such as Tesco and Rolls-Royce, would remove one of the fastest-growing FTSE 100 companies from the UK investment...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...“The AstraZeneca chief executive is French, not British, its operations are global, it’s not exactly Rolls-Royce,” says Steve Hewlett, a media commentator....
...His solution was to pool assets with Pfizer of the US, which also had a lacklustre HIV portfolio. This was the genesis of ViiV Healthcare, now 80 per cent owned by GSK....
...Yet it remains European in one important respect: its London listing puts it among the top quartile of the UK’s FTSE 100 index, bigger by market capitalisation than household names such as Tesco, Rolls-Royce...
...(Financial Times) Rolls-Royce is close to reaching an agreement to sell part of its energy division to Siemens in a deal valued at up to £1bn....
...Hermès also worked with the Four Seasons George V hotel in Paris to create a hand-built Rolls-Royce Phantom, custom-made to the hotel’s specifications....
...GM’s new Chinese-designed, Indian-made carChilean poverty data controversy reveals tough truths about country’s growthGeorgia: dark side of Rose RevolutionAudi revs up in MexicoColombia v Argentina: GDP...
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
..., Cheung Kong, BT, Vodafone Lord Sassoon Eon, EDF, Iberdrola, Centrica, RWE, Scottish & Southern Energy David Willetts Eisai, Novartis, Pfizer, Roche, AstraZeneca, GlaxoSmithKline, Johnson & Johnson...
...“At present, having built a Rolls-Royce to carry out health research in this country, we are driving it down a cart track.”...
...The figures came as Lord Green, the trade minister, announced that ministers would be paired with some of Britain’s biggest exporters – from Rolls-Royce to Tesco – as part of the coalition’s efforts to boost...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
International Edition